Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study
Hans J. Lee(Johns Hopkins University), Momen M. Wahidi(Northwestern University), Lonny Yarmus(Johns Hopkins University), Bailey Griscom(Veracyte (United States)), Lori Lofaro(Veracyte (United States)), Kyle Hogarth(University of Chicago), David Feller‐Kopman(Dartmouth–Hitchcock Medical Center), Peter J. Mazzone(Cleveland Clinic), Jing Huang(Veracyte (United States)), Giulia C. Kennedy(Veracyte (United States)), Yoonha Choi(Ewha Womans University), Sangeeta Bhorade(University of Chicago), Marla Johnson(University of Iowa), Avrum Spira(Boston University)
Cited by 25
Related Papers
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
|Cancer Cell|2012|652
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
|Cell|2020|602
Interferon Regulatory Factor 6 ( <i>IRF6</i> ) Gene Variants and the Risk of Isolated Cleft Lip or Palate
|New England Journal of Medicine|2004|583